Evaluation of Cell-free Fetal DNA as a Second-Trimester Maternal Serum Marker of Down Syndrome Pregnancy (original) (raw)

Quantitative analysis of DNA levels in maternal plasma in normal and Down syndrome pregnancies

BMC pregnancy and childbirth, 2002

Down syndrome and cell-free fetal DNA in archived maternal serum

American Journal of Obstetrics and Gynecology, 2002

Evaluating first trimester maternal serum screening combinations for Down syndrome suitable for use with reflexive secondary screening via sequencing of cell free DNA: high detection with low rates of invasive procedures

Geralyn Messerlian

Prenatal Diagnosis, 2015

View PDFchevron_right

Maternal serum screening for Down's syndrome in the first trimester of pregnancy

Ettore Cariati

BJOG: An International Journal of Obstetrics and Gynaecology, 1995

View PDFchevron_right

Maternal serum markers in screening for Down syndrome

Ann Tabor

Clinical Genetics, 2008

View PDFchevron_right

Cost-effectiveness threshold of first-trimester Down syndrome maternal serum screening for the use of cell-free DNA as a second-tier screening test

Sophie Dreux

Annales de Biologie Clinique, 2021

View PDFchevron_right

Down syndrome maternal serum marker screening after 18 weeks of gestation: a countrywide study

Isabelle Czerkiewicz

American Journal of Obstetrics and Gynecology, 2013

View PDFchevron_right

Feasibility of using plasma rather than serum in first and second trimester multiple marker Down's syndrome screening

Geralyn Messerlian

Journal of Medical Screening, 2012

View PDFchevron_right

Advances in prenatal screening for Down syndrome: I. General principles and second trimester testing

Peter Benn

Clinica Chimica Acta, 2002

View PDFchevron_right

The Effect of Fetal Gender on the Markers of First Trimester Down Syndrome Screening

ekrem Tok

2006

View PDFchevron_right

DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations

Geralyn Messerlian

Prenatal Diagnosis, 2012

View PDFchevron_right

α-Fetoprotein, free β-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome

John Owen

American Journal of Obstetrics and Gynecology, 1997

View PDFchevron_right

Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome

Nan Okun

Prenatal Diagnosis, 2010

View PDFchevron_right

Combining first and second trimester markers for Down syndrome screening: Think twice

Kate Brameld

Australian and New Zealand Journal of Obstetrics and Gynaecology, 2008

View PDFchevron_right

The utility of fetal biometry as an adjunct to the multiple-marker screening test for Down syndrome

John Owen

American Journal of Obstetrics and Gynecology, 1994

View PDFchevron_right

Maternal serum screening for Down's syndrome in early pregnancy

James Densem

BMJ, 1988

View PDFchevron_right

Noninvasive Prenatal Nucleic Acid Diagnostics of Down Syndrome

I. Dhaifalah

Genetics and Etiology of Down Syndrome, 2011

View PDFchevron_right

International Society for Prenatal Diagnosis Position Statement: cell free (cf)DNA screening for Down syndrome in multiple pregnancies

Yuval Yaron

Prenatal Diagnosis, 2020

View PDFchevron_right

Rapid prenatal diagnosis of Down syndrome using quantitative fluorescencein situ hybridization on interphase nuclei

Bernard Dutrillaux

Prenatal Diagnosis, 2003

View PDFchevron_right

Reproducibility of risk figures in 2nd-trimester maternal serum screening for Down syndrome: comparison of 2 laboratories

Peter Benn

Clinical chemistry, 2006

View PDFchevron_right

Performance and Predictive Value of First Trimester Screening Markers for Down Syndrome in Iranian Pregnancies

Mostafa Akbariqomi

Journal of Family & Reproductive Health, 2018

View PDFchevron_right

The utility of circulating LHCGR as a predictor of Down's syndrome in early pregnancy

Michael Pugia

BMC Pregnancy and Childbirth, 2014

View PDFchevron_right

Repeat maternal serum testing in multiple marker down's syndrome screening programmes

James Densem

Prenatal Diagnosis, 1994

View PDFchevron_right

New Developments in Prenatal Screening for Down Syndrome

Robert Mooney

Pathology Patterns Reviews, 2003

View PDFchevron_right

A prospective trial of prenatal screening for Down syndrome by means of maternal serum α-fetoprotein, human chorionic gonadotropin, and unconjugated estriol

Gail Prins

American Journal of Obstetrics and Gynecology, 1993

View PDFchevron_right

Review article Advances in prenatal screening for Down syndrome: II first trimester testing, integrated testing, and future directions

Peter Benn

2002

View PDFchevron_right

Down syndrome screening marker levels in women with a previous aneuploidy pregnancy

Kevin Spencer

Prenatal Diagnosis, 2005

View PDFchevron_right

The influence of different sample collection types on the levels of markers used for Down's syndrome screening as measured by the Kryptor Immunosassay system

Kevin Spencer

Annals of Clinical Biochemistry, 2003

View PDFchevron_right

Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011

Peter Benn

Prenatal diagnosis, 2012

View PDFchevron_right

Down’s Syndrome Screening in the First Trimester with Additional Serum Markers: Indian Parameters

Kanjaksha Ghosh

The Journal of Obstetrics and Gynecology of India, 2019

View PDFchevron_right

Evaluation of Cell-free Fetal DNA as a Second-Trimester Maternal Serum Marker of Down Syndrome Pregnancy (original) (raw)

Related papers